nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—kidney cancer	0.178	1	CbGaD
Captopril—ABCB1—Temsirolimus—kidney cancer	0.0422	0.13	CbGbCtD
Captopril—CYP2D6—Temsirolimus—kidney cancer	0.0397	0.123	CbGbCtD
Captopril—ALB—Erlotinib—kidney cancer	0.0302	0.0932	CbGbCtD
Captopril—REN—renal vein—kidney cancer	0.0284	0.168	CbGeAlD
Captopril—ABCB1—Pazopanib—kidney cancer	0.0221	0.0683	CbGbCtD
Captopril—CYP2D6—Pazopanib—kidney cancer	0.0209	0.0644	CbGbCtD
Captopril—REN—posterior vena cava—kidney cancer	0.0207	0.123	CbGeAlD
Captopril—ABCB1—Dactinomycin—kidney cancer	0.0203	0.0625	CbGbCtD
Captopril—REN—renal artery—kidney cancer	0.0191	0.113	CbGeAlD
Captopril—ABCB1—Gemcitabine—kidney cancer	0.016	0.0494	CbGbCtD
Captopril—ABCB1—Erlotinib—kidney cancer	0.0158	0.0488	CbGbCtD
Captopril—REN—collecting duct of renal tubule—kidney cancer	0.015	0.0889	CbGeAlD
Captopril—CYP2D6—Erlotinib—kidney cancer	0.0149	0.0459	CbGbCtD
Captopril—ABCB1—Paclitaxel—kidney cancer	0.0145	0.0446	CbGbCtD
Captopril—F2—posterior vena cava—kidney cancer	0.0144	0.0856	CbGeAlD
Captopril—ABCB1—Sorafenib—kidney cancer	0.0129	0.0396	CbGbCtD
Captopril—ABCB1—Vinblastine—kidney cancer	0.0127	0.0391	CbGbCtD
Captopril—ABCB1—Vincristine—kidney cancer	0.0125	0.0385	CbGbCtD
Captopril—CYP2D6—Sorafenib—kidney cancer	0.0121	0.0373	CbGbCtD
Captopril—CYP2D6—Vinblastine—kidney cancer	0.012	0.0369	CbGbCtD
Captopril—ABCB1—Sunitinib—kidney cancer	0.0104	0.0321	CbGbCtD
Captopril—ACE—renal artery—kidney cancer	0.00813	0.0482	CbGeAlD
Captopril—ABCB1—Doxorubicin—kidney cancer	0.0078	0.0241	CbGbCtD
Captopril—CYP2D6—Doxorubicin—kidney cancer	0.00735	0.0227	CbGbCtD
Captopril—REN—nephron—kidney cancer	0.00667	0.0396	CbGeAlD
Captopril—MMP2—nephron—kidney cancer	0.00614	0.0364	CbGeAlD
Captopril—REN—urine—kidney cancer	0.00535	0.0317	CbGeAlD
Captopril—F2—urine—kidney cancer	0.00373	0.0221	CbGeAlD
Captopril—ACE—nephron—kidney cancer	0.00284	0.0169	CbGeAlD
Captopril—ACE—urine—kidney cancer	0.00228	0.0135	CbGeAlD
Captopril—LTA4H—nephron tubule—kidney cancer	0.00187	0.0111	CbGeAlD
Captopril—LTA4H—renal system—kidney cancer	0.0017	0.0101	CbGeAlD
Captopril—LTA4H—kidney—kidney cancer	0.00164	0.00972	CbGeAlD
Captopril—LTA4H—cortex of kidney—kidney cancer	0.0016	0.00947	CbGeAlD
Captopril—LTA4H—gonad—kidney cancer	0.00152	0.00902	CbGeAlD
Captopril—LTA4H—cardiac atrium—kidney cancer	0.00152	0.00901	CbGeAlD
Captopril—REN—nephron tubule—kidney cancer	0.00144	0.00854	CbGeAlD
Captopril—REN—renal system—kidney cancer	0.00131	0.00776	CbGeAlD
Captopril—REN—kidney—kidney cancer	0.00127	0.0075	CbGeAlD
Captopril—REN—cortex of kidney—kidney cancer	0.00123	0.00731	CbGeAlD
Captopril—MMP2—renal system—kidney cancer	0.0012	0.00713	CbGeAlD
Captopril—REN—cardiac atrium—kidney cancer	0.00117	0.00695	CbGeAlD
Captopril—MMP2—kidney—kidney cancer	0.00116	0.0069	CbGeAlD
Captopril—MMP2—cortex of kidney—kidney cancer	0.00113	0.00672	CbGeAlD
Captopril—CYP2D6—urine—kidney cancer	0.00112	0.00662	CbGeAlD
Captopril—MMP2—gonad—kidney cancer	0.00108	0.0064	CbGeAlD
Captopril—MMP2—cardiac atrium—kidney cancer	0.00108	0.00639	CbGeAlD
Captopril—MMP9—renal system—kidney cancer	0.00105	0.00621	CbGeAlD
Captopril—SLC22A6—nephron tubule—kidney cancer	0.00103	0.0061	CbGeAlD
Captopril—MMP9—kidney—kidney cancer	0.00101	0.006	CbGeAlD
Captopril—F2—renal system—kidney cancer	0.000914	0.00541	CbGeAlD
Captopril—F2—kidney—kidney cancer	0.000883	0.00523	CbGeAlD
Captopril—SLC22A6—cortex of kidney—kidney cancer	0.000881	0.00522	CbGeAlD
Captopril—SLC15A1—nephron tubule—kidney cancer	0.000856	0.00507	CbGeAlD
Captopril—SLC15A1—renal system—kidney cancer	0.000779	0.00461	CbGeAlD
Captopril—SLC15A1—kidney—kidney cancer	0.000753	0.00446	CbGeAlD
Captopril—ACE—nephron tubule—kidney cancer	0.000614	0.00364	CbGeAlD
Captopril—ACE—renal system—kidney cancer	0.000558	0.00331	CbGeAlD
Captopril—ACE—kidney—kidney cancer	0.00054	0.0032	CbGeAlD
Captopril—ACE—cortex of kidney—kidney cancer	0.000526	0.00311	CbGeAlD
Captopril—ACE—gonad—kidney cancer	0.000501	0.00297	CbGeAlD
Captopril—ACE—cardiac atrium—kidney cancer	0.0005	0.00296	CbGeAlD
Captopril—CYP2D6—renal system—kidney cancer	0.000273	0.00162	CbGeAlD
Captopril—CYP2D6—kidney—kidney cancer	0.000264	0.00156	CbGeAlD
Captopril—ABCB1—nephron tubule—kidney cancer	0.000216	0.00128	CbGeAlD
Captopril—ABCB1—renal system—kidney cancer	0.000196	0.00116	CbGeAlD
Captopril—ABCB1—kidney—kidney cancer	0.00019	0.00113	CbGeAlD
Captopril—ABCB1—cortex of kidney—kidney cancer	0.000185	0.0011	CbGeAlD
Captopril—ABCB1—gonad—kidney cancer	0.000176	0.00104	CbGeAlD
Captopril—Nervousness—Paclitaxel—kidney cancer	0.000146	0.000748	CcSEcCtD
Captopril—Dizziness—Vinblastine—kidney cancer	0.000145	0.000744	CcSEcCtD
Captopril—Dizziness—Everolimus—kidney cancer	0.000145	0.000741	CcSEcCtD
Captopril—Abdominal pain—Sunitinib—kidney cancer	0.000145	0.00074	CcSEcCtD
Captopril—Body temperature increased—Sunitinib—kidney cancer	0.000145	0.00074	CcSEcCtD
Captopril—Diarrhoea—Erlotinib—kidney cancer	0.000145	0.00074	CcSEcCtD
Captopril—Hypotension—Vincristine—kidney cancer	0.000145	0.00074	CcSEcCtD
Captopril—Thrombocytopenia—Gemcitabine—kidney cancer	0.000144	0.000735	CcSEcCtD
Captopril—Renal failure acute—Doxorubicin—kidney cancer	0.000143	0.000733	CcSEcCtD
Captopril—Feeling abnormal—Dactinomycin—kidney cancer	0.000143	0.00073	CcSEcCtD
Captopril—Rhinitis—Capecitabine—kidney cancer	0.000142	0.000728	CcSEcCtD
Captopril—Hepatitis—Capecitabine—kidney cancer	0.000142	0.000726	CcSEcCtD
Captopril—Vision blurred—Paclitaxel—kidney cancer	0.000142	0.000726	CcSEcCtD
Captopril—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000142	0.000725	CcSEcCtD
Captopril—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000141	0.000721	CcSEcCtD
Captopril—Pharyngitis—Capecitabine—kidney cancer	0.000141	0.000721	CcSEcCtD
Captopril—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.00014	0.000717	CcSEcCtD
Captopril—Insomnia—Vincristine—kidney cancer	0.00014	0.000716	CcSEcCtD
Captopril—Anorexia—Gemcitabine—kidney cancer	0.00014	0.000716	CcSEcCtD
Captopril—Vomiting—Vinblastine—kidney cancer	0.00014	0.000715	CcSEcCtD
Captopril—Dizziness—Erlotinib—kidney cancer	0.00014	0.000715	CcSEcCtD
Captopril—Ill-defined disorder—Paclitaxel—kidney cancer	0.00014	0.000715	CcSEcCtD
Captopril—Vomiting—Everolimus—kidney cancer	0.000139	0.000713	CcSEcCtD
Captopril—Anaemia—Paclitaxel—kidney cancer	0.000139	0.000712	CcSEcCtD
Captopril—Paraesthesia—Vincristine—kidney cancer	0.000139	0.000711	CcSEcCtD
Captopril—Dermatitis bullous—Doxorubicin—kidney cancer	0.000138	0.000708	CcSEcCtD
Captopril—Rash—Everolimus—kidney cancer	0.000138	0.000707	CcSEcCtD
Captopril—Dermatitis—Everolimus—kidney cancer	0.000138	0.000706	CcSEcCtD
Captopril—Headache—Vinblastine—kidney cancer	0.000138	0.000705	CcSEcCtD
Captopril—Angioedema—Paclitaxel—kidney cancer	0.000138	0.000704	CcSEcCtD
Captopril—Headache—Everolimus—kidney cancer	0.000137	0.000702	CcSEcCtD
Captopril—Hypotension—Gemcitabine—kidney cancer	0.000137	0.000702	CcSEcCtD
Captopril—Abdominal pain—Dactinomycin—kidney cancer	0.000137	0.0007	CcSEcCtD
Captopril—Body temperature increased—Dactinomycin—kidney cancer	0.000137	0.0007	CcSEcCtD
Captopril—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000137	0.000699	CcSEcCtD
Captopril—Asthenia—Sorafenib—kidney cancer	0.000136	0.000698	CcSEcCtD
Captopril—Malaise—Paclitaxel—kidney cancer	0.000136	0.000695	CcSEcCtD
Captopril—Syncope—Paclitaxel—kidney cancer	0.000135	0.000691	CcSEcCtD
Captopril—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000135	0.000691	CcSEcCtD
Captopril—Decreased appetite—Vincristine—kidney cancer	0.000135	0.000688	CcSEcCtD
Captopril—Pruritus—Sorafenib—kidney cancer	0.000135	0.000688	CcSEcCtD
Captopril—Vomiting—Erlotinib—kidney cancer	0.000134	0.000687	CcSEcCtD
Captopril—Erythema multiforme—Capecitabine—kidney cancer	0.000134	0.000687	CcSEcCtD
Captopril—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000134	0.000684	CcSEcCtD
Captopril—Fatigue—Vincristine—kidney cancer	0.000133	0.000683	CcSEcCtD
Captopril—Rash—Erlotinib—kidney cancer	0.000133	0.000682	CcSEcCtD
Captopril—Dermatitis—Erlotinib—kidney cancer	0.000133	0.000681	CcSEcCtD
Captopril—Palpitations—Paclitaxel—kidney cancer	0.000133	0.000681	CcSEcCtD
Captopril—Hyponatraemia—Doxorubicin—kidney cancer	0.000133	0.00068	CcSEcCtD
Captopril—Insomnia—Gemcitabine—kidney cancer	0.000133	0.000679	CcSEcCtD
Captopril—Headache—Erlotinib—kidney cancer	0.000132	0.000677	CcSEcCtD
Captopril—Loss of consciousness—Paclitaxel—kidney cancer	0.000132	0.000677	CcSEcCtD
Captopril—Constipation—Vincristine—kidney cancer	0.000132	0.000677	CcSEcCtD
Captopril—Paraesthesia—Gemcitabine—kidney cancer	0.000132	0.000674	CcSEcCtD
Captopril—Flushing—Capecitabine—kidney cancer	0.000132	0.000674	CcSEcCtD
Captopril—Cough—Paclitaxel—kidney cancer	0.000131	0.000672	CcSEcCtD
Captopril—Asthenia—Sunitinib—kidney cancer	0.000131	0.000672	CcSEcCtD
Captopril—Dyspnoea—Gemcitabine—kidney cancer	0.000131	0.00067	CcSEcCtD
Captopril—Nausea—Vinblastine—kidney cancer	0.000131	0.000668	CcSEcCtD
Captopril—Somnolence—Gemcitabine—kidney cancer	0.000131	0.000668	CcSEcCtD
Captopril—Nausea—Everolimus—kidney cancer	0.00013	0.000666	CcSEcCtD
Captopril—Diarrhoea—Sorafenib—kidney cancer	0.00013	0.000666	CcSEcCtD
Captopril—Pruritus—Sunitinib—kidney cancer	0.000129	0.000662	CcSEcCtD
Captopril—Arthralgia—Paclitaxel—kidney cancer	0.000128	0.000656	CcSEcCtD
Captopril—Myalgia—Paclitaxel—kidney cancer	0.000128	0.000656	CcSEcCtD
Captopril—Chest pain—Paclitaxel—kidney cancer	0.000128	0.000656	CcSEcCtD
Captopril—Decreased appetite—Gemcitabine—kidney cancer	0.000128	0.000653	CcSEcCtD
Captopril—Discomfort—Paclitaxel—kidney cancer	0.000127	0.000648	CcSEcCtD
Captopril—Fatigue—Gemcitabine—kidney cancer	0.000127	0.000648	CcSEcCtD
Captopril—Gastrointestinal pain—Vincristine—kidney cancer	0.000127	0.000647	CcSEcCtD
Captopril—Cardiac arrest—Doxorubicin—kidney cancer	0.000126	0.000644	CcSEcCtD
Captopril—Dizziness—Sorafenib—kidney cancer	0.000126	0.000643	CcSEcCtD
Captopril—Constipation—Gemcitabine—kidney cancer	0.000126	0.000642	CcSEcCtD
Captopril—Nausea—Erlotinib—kidney cancer	0.000126	0.000642	CcSEcCtD
Captopril—Alopecia—Capecitabine—kidney cancer	0.000125	0.000642	CcSEcCtD
Captopril—Dry mouth—Paclitaxel—kidney cancer	0.000125	0.000642	CcSEcCtD
Captopril—Diarrhoea—Sunitinib—kidney cancer	0.000125	0.00064	CcSEcCtD
Captopril—Ataxia—Doxorubicin—kidney cancer	0.000124	0.000636	CcSEcCtD
Captopril—Asthenia—Dactinomycin—kidney cancer	0.000124	0.000636	CcSEcCtD
Captopril—Confusional state—Paclitaxel—kidney cancer	0.000124	0.000634	CcSEcCtD
Captopril—Anaphylactic shock—Paclitaxel—kidney cancer	0.000123	0.000629	CcSEcCtD
Captopril—Body temperature increased—Vincristine—kidney cancer	0.000122	0.000626	CcSEcCtD
Captopril—Abdominal pain—Vincristine—kidney cancer	0.000122	0.000626	CcSEcCtD
Captopril—Dysgeusia—Capecitabine—kidney cancer	0.000121	0.000619	CcSEcCtD
Captopril—Dizziness—Sunitinib—kidney cancer	0.000121	0.000619	CcSEcCtD
Captopril—Feeling abnormal—Gemcitabine—kidney cancer	0.000121	0.000619	CcSEcCtD
Captopril—Shock—Paclitaxel—kidney cancer	0.000121	0.000619	CcSEcCtD
Captopril—Vomiting—Sorafenib—kidney cancer	0.000121	0.000618	CcSEcCtD
Captopril—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000121	0.000618	CcSEcCtD
Captopril—Thrombocytopenia—Paclitaxel—kidney cancer	0.00012	0.000616	CcSEcCtD
Captopril—Tachycardia—Paclitaxel—kidney cancer	0.00012	0.000614	CcSEcCtD
Captopril—Rash—Sorafenib—kidney cancer	0.00012	0.000613	CcSEcCtD
Captopril—Dermatitis—Sorafenib—kidney cancer	0.00012	0.000613	CcSEcCtD
Captopril—Headache—Sorafenib—kidney cancer	0.000119	0.000609	CcSEcCtD
Captopril—Diarrhoea—Dactinomycin—kidney cancer	0.000119	0.000606	CcSEcCtD
Captopril—Anorexia—Paclitaxel—kidney cancer	0.000117	0.000599	CcSEcCtD
Captopril—Muscular weakness—Doxorubicin—kidney cancer	0.000117	0.000597	CcSEcCtD
Captopril—Vision blurred—Capecitabine—kidney cancer	0.000116	0.000596	CcSEcCtD
Captopril—Vomiting—Sunitinib—kidney cancer	0.000116	0.000595	CcSEcCtD
Captopril—Body temperature increased—Gemcitabine—kidney cancer	0.000116	0.000594	CcSEcCtD
Captopril—Rash—Sunitinib—kidney cancer	0.000115	0.00059	CcSEcCtD
Captopril—Dermatitis—Sunitinib—kidney cancer	0.000115	0.00059	CcSEcCtD
Captopril—Hypotension—Paclitaxel—kidney cancer	0.000115	0.000588	CcSEcCtD
Captopril—Ill-defined disorder—Capecitabine—kidney cancer	0.000115	0.000587	CcSEcCtD
Captopril—Headache—Sunitinib—kidney cancer	0.000115	0.000586	CcSEcCtD
Captopril—Anaemia—Capecitabine—kidney cancer	0.000114	0.000584	CcSEcCtD
Captopril—Eosinophilia—Doxorubicin—kidney cancer	0.000113	0.000579	CcSEcCtD
Captopril—Nausea—Sorafenib—kidney cancer	0.000113	0.000578	CcSEcCtD
Captopril—Pancreatitis—Doxorubicin—kidney cancer	0.000112	0.000573	CcSEcCtD
Captopril—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000112	0.000573	CcSEcCtD
Captopril—Malaise—Capecitabine—kidney cancer	0.000111	0.00057	CcSEcCtD
Captopril—Angina pectoris—Doxorubicin—kidney cancer	0.000111	0.00057	CcSEcCtD
Captopril—Insomnia—Paclitaxel—kidney cancer	0.000111	0.000569	CcSEcCtD
Captopril—Asthenia—Vincristine—kidney cancer	0.000111	0.000568	CcSEcCtD
Captopril—Syncope—Capecitabine—kidney cancer	0.000111	0.000567	CcSEcCtD
Captopril—Paraesthesia—Paclitaxel—kidney cancer	0.00011	0.000565	CcSEcCtD
Captopril—Vomiting—Dactinomycin—kidney cancer	0.00011	0.000563	CcSEcCtD
Captopril—Dyspnoea—Paclitaxel—kidney cancer	0.00011	0.000561	CcSEcCtD
Captopril—Somnolence—Paclitaxel—kidney cancer	0.000109	0.000559	CcSEcCtD
Captopril—Palpitations—Capecitabine—kidney cancer	0.000109	0.000559	CcSEcCtD
Captopril—Rash—Dactinomycin—kidney cancer	0.000109	0.000559	CcSEcCtD
Captopril—Nausea—Sunitinib—kidney cancer	0.000109	0.000556	CcSEcCtD
Captopril—Loss of consciousness—Capecitabine—kidney cancer	0.000109	0.000556	CcSEcCtD
Captopril—Pancytopenia—Doxorubicin—kidney cancer	0.000109	0.000556	CcSEcCtD
Captopril—Dyspepsia—Paclitaxel—kidney cancer	0.000108	0.000554	CcSEcCtD
Captopril—Cough—Capecitabine—kidney cancer	0.000108	0.000552	CcSEcCtD
Captopril—Neutropenia—Doxorubicin—kidney cancer	0.000107	0.000547	CcSEcCtD
Captopril—Decreased appetite—Paclitaxel—kidney cancer	0.000107	0.000547	CcSEcCtD
Captopril—Fatigue—Paclitaxel—kidney cancer	0.000106	0.000542	CcSEcCtD
Captopril—Diarrhoea—Vincristine—kidney cancer	0.000106	0.000542	CcSEcCtD
Captopril—Pollakiuria—Doxorubicin—kidney cancer	0.000106	0.00054	CcSEcCtD
Captopril—Asthenia—Gemcitabine—kidney cancer	0.000105	0.000539	CcSEcCtD
Captopril—Chest pain—Capecitabine—kidney cancer	0.000105	0.000538	CcSEcCtD
Captopril—Myalgia—Capecitabine—kidney cancer	0.000105	0.000538	CcSEcCtD
Captopril—Arthralgia—Capecitabine—kidney cancer	0.000105	0.000538	CcSEcCtD
Captopril—Constipation—Paclitaxel—kidney cancer	0.000105	0.000538	CcSEcCtD
Captopril—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000104	0.000534	CcSEcCtD
Captopril—Discomfort—Capecitabine—kidney cancer	0.000104	0.000532	CcSEcCtD
Captopril—Pruritus—Gemcitabine—kidney cancer	0.000104	0.000531	CcSEcCtD
Captopril—Weight decreased—Doxorubicin—kidney cancer	0.000103	0.000529	CcSEcCtD
Captopril—Dry mouth—Capecitabine—kidney cancer	0.000103	0.000526	CcSEcCtD
Captopril—Nausea—Dactinomycin—kidney cancer	0.000103	0.000526	CcSEcCtD
Captopril—Dizziness—Vincristine—kidney cancer	0.000102	0.000524	CcSEcCtD
Captopril—Confusional state—Capecitabine—kidney cancer	0.000102	0.00052	CcSEcCtD
Captopril—Feeling abnormal—Paclitaxel—kidney cancer	0.000101	0.000518	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000101	0.000517	CcSEcCtD
Captopril—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000101	0.000514	CcSEcCtD
Captopril—Diarrhoea—Gemcitabine—kidney cancer	0.0001	0.000514	CcSEcCtD
Captopril—Renal failure—Doxorubicin—kidney cancer	0.0001	0.000513	CcSEcCtD
Captopril—Jaundice—Doxorubicin—kidney cancer	9.94e-05	0.000508	CcSEcCtD
Captopril—Stomatitis—Doxorubicin—kidney cancer	9.94e-05	0.000508	CcSEcCtD
Captopril—Shock—Capecitabine—kidney cancer	9.92e-05	0.000508	CcSEcCtD
Captopril—Thrombocytopenia—Capecitabine—kidney cancer	9.88e-05	0.000505	CcSEcCtD
Captopril—Tachycardia—Capecitabine—kidney cancer	9.84e-05	0.000504	CcSEcCtD
Captopril—Vomiting—Vincristine—kidney cancer	9.84e-05	0.000503	CcSEcCtD
Captopril—Rash—Vincristine—kidney cancer	9.76e-05	0.000499	CcSEcCtD
Captopril—Dermatitis—Vincristine—kidney cancer	9.75e-05	0.000499	CcSEcCtD
Captopril—Body temperature increased—Paclitaxel—kidney cancer	9.72e-05	0.000497	CcSEcCtD
Captopril—Abdominal pain—Paclitaxel—kidney cancer	9.72e-05	0.000497	CcSEcCtD
Captopril—Headache—Vincristine—kidney cancer	9.69e-05	0.000496	CcSEcCtD
Captopril—Anorexia—Capecitabine—kidney cancer	9.61e-05	0.000492	CcSEcCtD
Captopril—Agranulocytosis—Doxorubicin—kidney cancer	9.51e-05	0.000487	CcSEcCtD
Captopril—Hypotension—Capecitabine—kidney cancer	9.42e-05	0.000482	CcSEcCtD
Captopril—Vomiting—Gemcitabine—kidney cancer	9.33e-05	0.000478	CcSEcCtD
Captopril—Rash—Gemcitabine—kidney cancer	9.26e-05	0.000474	CcSEcCtD
Captopril—Dermatitis—Gemcitabine—kidney cancer	9.25e-05	0.000473	CcSEcCtD
Captopril—Headache—Gemcitabine—kidney cancer	9.2e-05	0.000471	CcSEcCtD
Captopril—Nausea—Vincristine—kidney cancer	9.19e-05	0.00047	CcSEcCtD
Captopril—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.19e-05	0.00047	CcSEcCtD
Captopril—Rhinitis—Doxorubicin—kidney cancer	9.17e-05	0.000469	CcSEcCtD
Captopril—Hepatitis—Doxorubicin—kidney cancer	9.15e-05	0.000468	CcSEcCtD
Captopril—Insomnia—Capecitabine—kidney cancer	9.12e-05	0.000467	CcSEcCtD
Captopril—Pharyngitis—Doxorubicin—kidney cancer	9.08e-05	0.000465	CcSEcCtD
Captopril—Paraesthesia—Capecitabine—kidney cancer	9.06e-05	0.000463	CcSEcCtD
Captopril—Dyspnoea—Capecitabine—kidney cancer	8.99e-05	0.00046	CcSEcCtD
Captopril—Dyspepsia—Capecitabine—kidney cancer	8.88e-05	0.000454	CcSEcCtD
Captopril—Asthenia—Paclitaxel—kidney cancer	8.82e-05	0.000451	CcSEcCtD
Captopril—Decreased appetite—Capecitabine—kidney cancer	8.77e-05	0.000449	CcSEcCtD
Captopril—Nausea—Gemcitabine—kidney cancer	8.72e-05	0.000446	CcSEcCtD
Captopril—Fatigue—Capecitabine—kidney cancer	8.7e-05	0.000445	CcSEcCtD
Captopril—Pruritus—Paclitaxel—kidney cancer	8.7e-05	0.000445	CcSEcCtD
Captopril—Erythema multiforme—Doxorubicin—kidney cancer	8.65e-05	0.000443	CcSEcCtD
Captopril—Constipation—Capecitabine—kidney cancer	8.63e-05	0.000441	CcSEcCtD
Captopril—Flushing—Doxorubicin—kidney cancer	8.49e-05	0.000435	CcSEcCtD
Captopril—Diarrhoea—Paclitaxel—kidney cancer	8.41e-05	0.00043	CcSEcCtD
Captopril—Feeling abnormal—Capecitabine—kidney cancer	8.31e-05	0.000425	CcSEcCtD
Captopril—Gastrointestinal pain—Capecitabine—kidney cancer	8.25e-05	0.000422	CcSEcCtD
Captopril—Dizziness—Paclitaxel—kidney cancer	8.13e-05	0.000416	CcSEcCtD
Captopril—Alopecia—Doxorubicin—kidney cancer	8.09e-05	0.000414	CcSEcCtD
Captopril—Body temperature increased—Capecitabine—kidney cancer	7.97e-05	0.000408	CcSEcCtD
Captopril—Abdominal pain—Capecitabine—kidney cancer	7.97e-05	0.000408	CcSEcCtD
Captopril—Tension—Doxorubicin—kidney cancer	7.82e-05	0.0004	CcSEcCtD
Captopril—Vomiting—Paclitaxel—kidney cancer	7.81e-05	0.0004	CcSEcCtD
Captopril—Dysgeusia—Doxorubicin—kidney cancer	7.8e-05	0.000399	CcSEcCtD
Captopril—Rash—Paclitaxel—kidney cancer	7.75e-05	0.000396	CcSEcCtD
Captopril—Dermatitis—Paclitaxel—kidney cancer	7.74e-05	0.000396	CcSEcCtD
Captopril—Nervousness—Doxorubicin—kidney cancer	7.74e-05	0.000396	CcSEcCtD
Captopril—Headache—Paclitaxel—kidney cancer	7.7e-05	0.000394	CcSEcCtD
Captopril—Vision blurred—Doxorubicin—kidney cancer	7.51e-05	0.000384	CcSEcCtD
Captopril—Ill-defined disorder—Doxorubicin—kidney cancer	7.39e-05	0.000378	CcSEcCtD
Captopril—Anaemia—Doxorubicin—kidney cancer	7.36e-05	0.000377	CcSEcCtD
Captopril—Nausea—Paclitaxel—kidney cancer	7.3e-05	0.000374	CcSEcCtD
Captopril—Asthenia—Capecitabine—kidney cancer	7.24e-05	0.00037	CcSEcCtD
Captopril—Malaise—Doxorubicin—kidney cancer	7.18e-05	0.000368	CcSEcCtD
Captopril—Syncope—Doxorubicin—kidney cancer	7.14e-05	0.000366	CcSEcCtD
Captopril—Pruritus—Capecitabine—kidney cancer	7.14e-05	0.000365	CcSEcCtD
Captopril—Palpitations—Doxorubicin—kidney cancer	7.04e-05	0.00036	CcSEcCtD
Captopril—Loss of consciousness—Doxorubicin—kidney cancer	7e-05	0.000358	CcSEcCtD
Captopril—Cough—Doxorubicin—kidney cancer	6.95e-05	0.000356	CcSEcCtD
Captopril—Diarrhoea—Capecitabine—kidney cancer	6.9e-05	0.000353	CcSEcCtD
Captopril—Myalgia—Doxorubicin—kidney cancer	6.78e-05	0.000347	CcSEcCtD
Captopril—Chest pain—Doxorubicin—kidney cancer	6.78e-05	0.000347	CcSEcCtD
Captopril—Arthralgia—Doxorubicin—kidney cancer	6.78e-05	0.000347	CcSEcCtD
Captopril—Discomfort—Doxorubicin—kidney cancer	6.7e-05	0.000343	CcSEcCtD
Captopril—Dizziness—Capecitabine—kidney cancer	6.67e-05	0.000341	CcSEcCtD
Captopril—Dry mouth—Doxorubicin—kidney cancer	6.63e-05	0.000339	CcSEcCtD
Captopril—Confusional state—Doxorubicin—kidney cancer	6.56e-05	0.000335	CcSEcCtD
Captopril—Anaphylactic shock—Doxorubicin—kidney cancer	6.5e-05	0.000333	CcSEcCtD
Captopril—Vomiting—Capecitabine—kidney cancer	6.41e-05	0.000328	CcSEcCtD
Captopril—Shock—Doxorubicin—kidney cancer	6.4e-05	0.000327	CcSEcCtD
Captopril—Thrombocytopenia—Doxorubicin—kidney cancer	6.37e-05	0.000326	CcSEcCtD
Captopril—Rash—Capecitabine—kidney cancer	6.36e-05	0.000325	CcSEcCtD
Captopril—Dermatitis—Capecitabine—kidney cancer	6.35e-05	0.000325	CcSEcCtD
Captopril—Tachycardia—Doxorubicin—kidney cancer	6.35e-05	0.000325	CcSEcCtD
Captopril—Headache—Capecitabine—kidney cancer	6.32e-05	0.000323	CcSEcCtD
Captopril—Anorexia—Doxorubicin—kidney cancer	6.2e-05	0.000317	CcSEcCtD
Captopril—Hypotension—Doxorubicin—kidney cancer	6.08e-05	0.000311	CcSEcCtD
Captopril—Nausea—Capecitabine—kidney cancer	5.99e-05	0.000307	CcSEcCtD
Captopril—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.92e-05	0.000303	CcSEcCtD
Captopril—Insomnia—Doxorubicin—kidney cancer	5.88e-05	0.000301	CcSEcCtD
Captopril—Paraesthesia—Doxorubicin—kidney cancer	5.84e-05	0.000299	CcSEcCtD
Captopril—Dyspnoea—Doxorubicin—kidney cancer	5.8e-05	0.000297	CcSEcCtD
Captopril—Somnolence—Doxorubicin—kidney cancer	5.78e-05	0.000296	CcSEcCtD
Captopril—Dyspepsia—Doxorubicin—kidney cancer	5.72e-05	0.000293	CcSEcCtD
Captopril—Decreased appetite—Doxorubicin—kidney cancer	5.65e-05	0.000289	CcSEcCtD
Captopril—Fatigue—Doxorubicin—kidney cancer	5.61e-05	0.000287	CcSEcCtD
Captopril—Constipation—Doxorubicin—kidney cancer	5.56e-05	0.000284	CcSEcCtD
Captopril—Feeling abnormal—Doxorubicin—kidney cancer	5.36e-05	0.000274	CcSEcCtD
Captopril—Gastrointestinal pain—Doxorubicin—kidney cancer	5.32e-05	0.000272	CcSEcCtD
Captopril—Abdominal pain—Doxorubicin—kidney cancer	5.14e-05	0.000263	CcSEcCtD
Captopril—Body temperature increased—Doxorubicin—kidney cancer	5.14e-05	0.000263	CcSEcCtD
Captopril—Asthenia—Doxorubicin—kidney cancer	4.66e-05	0.000239	CcSEcCtD
Captopril—Pruritus—Doxorubicin—kidney cancer	4.6e-05	0.000235	CcSEcCtD
Captopril—Diarrhoea—Doxorubicin—kidney cancer	4.45e-05	0.000228	CcSEcCtD
Captopril—Dizziness—Doxorubicin—kidney cancer	4.3e-05	0.00022	CcSEcCtD
Captopril—Vomiting—Doxorubicin—kidney cancer	4.13e-05	0.000211	CcSEcCtD
Captopril—Rash—Doxorubicin—kidney cancer	4.1e-05	0.00021	CcSEcCtD
Captopril—Dermatitis—Doxorubicin—kidney cancer	4.1e-05	0.00021	CcSEcCtD
Captopril—Headache—Doxorubicin—kidney cancer	4.07e-05	0.000208	CcSEcCtD
Captopril—Nausea—Doxorubicin—kidney cancer	3.86e-05	0.000198	CcSEcCtD
Captopril—LTA4H—Metabolism—PIK3CA—kidney cancer	2.57e-05	0.000192	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.56e-05	0.000192	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.55e-05	0.000191	CbGpPWpGaD
Captopril—ALB—Metabolism—PDHB—kidney cancer	2.54e-05	0.00019	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—kidney cancer	2.53e-05	0.00019	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACY1—kidney cancer	2.46e-05	0.000185	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ANXA1—kidney cancer	2.41e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSC1—kidney cancer	2.41e-05	0.000181	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PSMD7—kidney cancer	2.41e-05	0.000181	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRB7—kidney cancer	2.39e-05	0.000179	CbGpPWpGaD
Captopril—ALB—Metabolism—CCBL1—kidney cancer	2.39e-05	0.000179	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—FLT1—kidney cancer	2.33e-05	0.000175	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—kidney cancer	2.23e-05	0.000167	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PDHB—kidney cancer	2.22e-05	0.000167	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ITPR2—kidney cancer	2.22e-05	0.000166	CbGpPWpGaD
Captopril—F2—Hemostasis—RAF1—kidney cancer	2.22e-05	0.000166	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUNB—kidney cancer	2.16e-05	0.000162	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PAK1—kidney cancer	2.16e-05	0.000162	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.16e-05	0.000162	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.14e-05	0.00016	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—POMC—kidney cancer	2.12e-05	0.000159	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK3—kidney cancer	2.11e-05	0.000158	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PDHB—kidney cancer	2.1e-05	0.000157	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CCBL1—kidney cancer	2.09e-05	0.000157	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—POMC—kidney cancer	2.09e-05	0.000157	CbGpPWpGaD
Captopril—ALB—Metabolism—GLIPR1—kidney cancer	2.07e-05	0.000155	CbGpPWpGaD
Captopril—ALB—Metabolism—PPAT—kidney cancer	2.07e-05	0.000155	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.04e-05	0.000153	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.02e-05	0.000152	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNA1—kidney cancer	2.01e-05	0.000151	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—MAPK1—kidney cancer	2.01e-05	0.00015	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EIF4EBP1—kidney cancer	2e-05	0.00015	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HSPB1—kidney cancer	2e-05	0.00015	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—kidney cancer	1.99e-05	0.000149	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.97e-05	0.000148	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CCBL1—kidney cancer	1.97e-05	0.000148	CbGpPWpGaD
Captopril—ALB—Metabolism—FH—kidney cancer	1.92e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Metabolism—APRT—kidney cancer	1.92e-05	0.000144	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA1—kidney cancer	1.91e-05	0.000143	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KRAS—kidney cancer	1.9e-05	0.000142	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.88e-05	0.000141	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PSMD7—kidney cancer	1.86e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ANXA1—kidney cancer	1.86e-05	0.000139	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC1—kidney cancer	1.86e-05	0.000139	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GLIPR1—kidney cancer	1.81e-05	0.000136	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PPAT—kidney cancer	1.81e-05	0.000136	CbGpPWpGaD
Captopril—ALB—Metabolism—GPC3—kidney cancer	1.81e-05	0.000136	CbGpPWpGaD
Captopril—F2—Signaling Pathways—FLT1—kidney cancer	1.8e-05	0.000135	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA2—kidney cancer	1.78e-05	0.000133	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF2—kidney cancer	1.77e-05	0.000133	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.77e-05	0.000132	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN2B—kidney cancer	1.76e-05	0.000132	CbGpPWpGaD
Captopril—ALB—Metabolism—CA2—kidney cancer	1.76e-05	0.000132	CbGpPWpGaD
Captopril—ALB—Metabolism—ALAD—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IGF1R—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PPAT—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.71e-05	0.000128	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—POMC—kidney cancer	1.7e-05	0.000127	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—kidney cancer	1.69e-05	0.000127	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APRT—kidney cancer	1.69e-05	0.000126	CbGpPWpGaD
Captopril—ABCB1—Metabolism—FH—kidney cancer	1.69e-05	0.000126	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.68e-05	0.000126	CbGpPWpGaD
Captopril—ALB—Metabolism—ST3GAL2—kidney cancer	1.67e-05	0.000125	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUNB—kidney cancer	1.67e-05	0.000125	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PAK1—kidney cancer	1.67e-05	0.000125	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.66e-05	0.000125	CbGpPWpGaD
Captopril—ALB—Metabolism—ALDH1A1—kidney cancer	1.64e-05	0.000123	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.63e-05	0.000122	CbGpPWpGaD
Captopril—ALB—Hemostasis—IGF2—kidney cancer	1.6e-05	0.00012	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK3—kidney cancer	1.6e-05	0.00012	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APRT—kidney cancer	1.59e-05	0.000119	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—FH—kidney cancer	1.59e-05	0.000119	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GPC3—kidney cancer	1.58e-05	0.000119	CbGpPWpGaD
Captopril—ALB—Metabolism—PGK1—kidney cancer	1.57e-05	0.000117	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A3—kidney cancer	1.57e-05	0.000117	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.55e-05	0.000116	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—POMC—kidney cancer	1.54e-05	0.000116	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA2—kidney cancer	1.54e-05	0.000116	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.54e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Metabolism—LDHB—kidney cancer	1.54e-05	0.000115	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.53e-05	0.000115	CbGpPWpGaD
Captopril—F2—Hemostasis—MAPK1—kidney cancer	1.52e-05	0.000114	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CTNNB1—kidney cancer	1.51e-05	0.000113	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALAD—kidney cancer	1.5e-05	0.000113	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.49e-05	0.000112	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GPC3—kidney cancer	1.49e-05	0.000112	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.47e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.47e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.47e-05	0.00011	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.47e-05	0.00011	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.45e-05	0.000109	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA2—kidney cancer	1.45e-05	0.000109	CbGpPWpGaD
Captopril—F2—Hemostasis—KRAS—kidney cancer	1.44e-05	0.000108	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.43e-05	0.000107	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.42e-05	0.000106	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALAD—kidney cancer	1.42e-05	0.000106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HIF1A—kidney cancer	1.41e-05	0.000106	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TSC2—kidney cancer	1.4e-05	0.000105	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.38e-05	0.000104	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PGK1—kidney cancer	1.37e-05	0.000103	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A3—kidney cancer	1.37e-05	0.000103	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF2—kidney cancer	1.37e-05	0.000102	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN2B—kidney cancer	1.36e-05	0.000102	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.35e-05	0.000101	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LDHB—kidney cancer	1.35e-05	0.000101	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—kidney cancer	1.35e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.35e-05	0.000101	CbGpPWpGaD
Captopril—ALB—Metabolism—CA9—kidney cancer	1.33e-05	9.99e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IGF1R—kidney cancer	1.32e-05	9.9e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—PIK3CA—kidney cancer	1.32e-05	9.89e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.3e-05	9.76e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.3e-05	9.75e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.29e-05	9.7e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PGK1—kidney cancer	1.29e-05	9.7e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.28e-05	9.6e-05	CbGpPWpGaD
Captopril—F2—Hemostasis—TP53—kidney cancer	1.28e-05	9.57e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RAF1—kidney cancer	1.27e-05	9.54e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LDHB—kidney cancer	1.27e-05	9.51e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—kidney cancer	1.26e-05	9.42e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APC—kidney cancer	1.24e-05	9.3e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KIT—kidney cancer	1.24e-05	9.3e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.23e-05	9.22e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.21e-05	9.08e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—POMC—kidney cancer	1.18e-05	8.85e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.18e-05	8.83e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.17e-05	8.77e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA9—kidney cancer	1.17e-05	8.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—BRAF—kidney cancer	1.17e-05	8.74e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.15e-05	8.64e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—kidney cancer	1.14e-05	8.55e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CRABP1—kidney cancer	1.13e-05	8.49e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA9—kidney cancer	1.1e-05	8.25e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.09e-05	8.16e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HIF1A—kidney cancer	1.09e-05	8.15e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TSC2—kidney cancer	1.08e-05	8.13e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ITPR2—kidney cancer	1.05e-05	7.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—kidney cancer	1.04e-05	7.79e-05	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.02e-05	7.61e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1e-05	7.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CRABP1—kidney cancer	9.93e-06	7.44e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RAF1—kidney cancer	9.74e-06	7.3e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.72e-06	7.28e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RELA—kidney cancer	9.69e-06	7.26e-05	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	9.68e-06	7.25e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ERBB2—kidney cancer	9.63e-06	7.22e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ACHE—kidney cancer	9.61e-06	7.2e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTT1—kidney cancer	9.61e-06	7.2e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KIT—kidney cancer	9.58e-06	7.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APC—kidney cancer	9.58e-06	7.18e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MTOR—kidney cancer	9.51e-06	7.12e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CRABP1—kidney cancer	9.36e-06	7.01e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ITPR2—kidney cancer	9.23e-06	6.92e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK3—kidney cancer	9.17e-06	6.87e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—POMC—kidney cancer	9.12e-06	6.83e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SCARB1—kidney cancer	9.1e-06	6.82e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS1—kidney cancer	9.01e-06	6.75e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—BRAF—kidney cancer	9e-06	6.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CDKN1B—kidney cancer	8.92e-06	6.69e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PSMD7—kidney cancer	8.83e-06	6.62e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAF1—kidney cancer	8.8e-06	6.59e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—kidney cancer	8.73e-06	6.54e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—MAPK1—kidney cancer	8.73e-06	6.54e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ITPR2—kidney cancer	8.7e-06	6.52e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCND1—kidney cancer	8.51e-06	6.38e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—JUN—kidney cancer	8.49e-06	6.36e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CTNNB1—kidney cancer	8.43e-06	6.32e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTT1—kidney cancer	8.42e-06	6.31e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ACHE—kidney cancer	8.42e-06	6.31e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—BCHE—kidney cancer	8.37e-06	6.27e-05	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—PIK3CA—kidney cancer	8.34e-06	6.25e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC5A5—kidney cancer	8.27e-06	6.2e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—KRAS—kidney cancer	8.24e-06	6.18e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PTEN—kidney cancer	8.21e-06	6.16e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC2A1—kidney cancer	7.99e-06	5.99e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SCARB1—kidney cancer	7.97e-06	5.97e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ACHE—kidney cancer	7.94e-06	5.95e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTT1—kidney cancer	7.94e-06	5.95e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS1—kidney cancer	7.89e-06	5.91e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—kidney cancer	7.89e-06	5.91e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.75e-06	5.81e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PSMD7—kidney cancer	7.74e-06	5.8e-05	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	7.62e-06	5.71e-05	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—PIK3CA—kidney cancer	7.57e-06	5.68e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RAF1—kidney cancer	7.52e-06	5.63e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SCARB1—kidney cancer	7.51e-06	5.63e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RELA—kidney cancer	7.48e-06	5.61e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ERBB2—kidney cancer	7.44e-06	5.57e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS1—kidney cancer	7.44e-06	5.57e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—kidney cancer	7.42e-06	5.56e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—kidney cancer	7.34e-06	5.5e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—BCHE—kidney cancer	7.34e-06	5.5e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PSMD7—kidney cancer	7.29e-06	5.46e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC5A5—kidney cancer	7.25e-06	5.43e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK3—kidney cancer	7.02e-06	5.26e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC2A1—kidney cancer	7e-06	5.24e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—BCHE—kidney cancer	6.91e-06	5.18e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CDKN1B—kidney cancer	6.89e-06	5.16e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.83e-06	5.12e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MYC—kidney cancer	6.83e-06	5.12e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.76e-06	5.06e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—kidney cancer	6.74e-06	5.05e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—kidney cancer	6.7e-06	5.02e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—MAPK1—kidney cancer	6.68e-06	5e-05	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	6.67e-06	5e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTP1—kidney cancer	6.66e-06	4.99e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC2A1—kidney cancer	6.59e-06	4.94e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCND1—kidney cancer	6.57e-06	4.92e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—JUN—kidney cancer	6.56e-06	4.91e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CTNNB1—kidney cancer	6.51e-06	4.88e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK3—kidney cancer	6.34e-06	4.75e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PTEN—kidney cancer	6.34e-06	4.75e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KRAS—kidney cancer	6.31e-06	4.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—ABCB1—kidney cancer	6.31e-06	4.73e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—GSTM1—kidney cancer	6.12e-06	4.59e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—MAPK1—kidney cancer	6.03e-06	4.52e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTP1—kidney cancer	5.84e-06	4.37e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—CYP1A1—kidney cancer	5.8e-06	4.35e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—PIK3CA—kidney cancer	5.8e-06	4.34e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—kidney cancer	5.73e-06	4.29e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—KRAS—kidney cancer	5.7e-06	4.27e-05	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—kidney cancer	5.61e-06	4.2e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTP1—kidney cancer	5.5e-06	4.12e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK3—kidney cancer	5.42e-06	4.06e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—GSTM1—kidney cancer	5.36e-06	4.02e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MYC—kidney cancer	5.27e-06	3.95e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—PIK3CA—kidney cancer	5.24e-06	3.92e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ABCB1—kidney cancer	5.21e-06	3.9e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MAPK1—kidney cancer	5.16e-06	3.86e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CYP1A1—kidney cancer	5.08e-06	3.81e-05	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—kidney cancer	5.07e-06	3.8e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—GSTM1—kidney cancer	5.05e-06	3.79e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KRAS—kidney cancer	4.87e-06	3.65e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.79e-06	3.59e-05	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.77e-06	3.57e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—PIK3CA—kidney cancer	4.47e-06	3.35e-05	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—kidney cancer	4.33e-06	3.24e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—POMC—kidney cancer	4.33e-06	3.24e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—POMC—kidney cancer	3.79e-06	2.84e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—POMC—kidney cancer	3.57e-06	2.68e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTGS2—kidney cancer	3.45e-06	2.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTGS2—kidney cancer	3.02e-06	2.27e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PTEN—kidney cancer	3.01e-06	2.26e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTGS2—kidney cancer	2.85e-06	2.14e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PTEN—kidney cancer	2.64e-06	1.98e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PTEN—kidney cancer	2.48e-06	1.86e-05	CbGpPWpGaD
Captopril—ALB—Metabolism—PIK3CA—kidney cancer	2.12e-06	1.59e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—PIK3CA—kidney cancer	1.86e-06	1.39e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.75e-06	1.31e-05	CbGpPWpGaD
